Organon & Co. Statistics

Total Valuation

Organon & Co. has a market cap or net worth of EUR 2.10 billion. The enterprise value is 9.18 billion.

Market Cap	2.10B
Enterprise Value	9.18B

Important Dates

The last earnings date was Thursday, August 7, 2025.

Earnings Date	Aug 7, 2025
Ex-Dividend Date	Aug 14, 2025

Share Statistics

Current Share Class	259.97M
Shares Outstanding	n/a
Shares Change (YoY)	+1.06%
Shares Change (QoQ)	-0.32%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	258.73M

Valuation Ratios

The trailing PE ratio is 3.52 and the forward PE ratio is 2.47.

PE Ratio	3.52
Forward PE	2.47
PS Ratio	0.39
PB Ratio	3.36
P/TBV Ratio	n/a
P/FCF Ratio	3.74
P/OCF Ratio	2.98
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 6.18, with an EV/FCF ratio of 16.39.

EV / Earnings	15.40
EV / Sales	1.71
EV / EBITDA	6.18
EV / EBIT	7.92
EV / FCF	16.39

Financial Position

The company has a current ratio of 1.65, with a Debt / Equity ratio of 12.14.

Current Ratio	1.65
Quick Ratio	0.75
Debt / Equity	12.14
Debt / EBITDA	5.11
Debt / FCF	13.52
Interest Coverage	2.65

Financial Efficiency

Return on equity (ROE) is 159.64% and return on invested capital (ROIC) is 9.21%.

Return on Equity (ROE)	159.64%
Return on Assets (ROA)	6.62%
Return on Invested Capital (ROIC)	9.21%
Return on Capital Employed (ROCE)	12.69%
Revenue Per Employee	534,827
Profits Per Employee	59,605
Employee Count	10,000
Asset Turnover	0.49
Inventory Turnover	1.99

Taxes

Income Tax	-28.95M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -56.18% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-56.18%
50-Day Moving Average	8.49
200-Day Moving Average	12.33
Relative Strength Index (RSI)	13.37
Average Volume (20 Days)	195

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	3.35

Income Statement

In the last 12 months, Organon & Co. had revenue of EUR 5.35 billion and earned 596.05 million in profits. Earnings per share was 2.29.

Revenue	5.35B
Gross Profit	3.03B
Operating Income	1.16B
Pretax Income	567.10M
Net Income	596.05M
EBITDA	1.43B
EBIT	1.16B
Earnings Per Share (EPS)	2.29

Full Income Statement

Balance Sheet

The company has 510.05 million in cash and 7.57 billion in debt, giving a net cash position of -7.06 billion.

Cash & Cash Equivalents	510.05M
Total Debt	7.57B
Net Cash	-7.06B
Net Cash Per Share	n/a
Equity (Book Value)	624.15M
Book Value Per Share	2.40
Working Capital	1.55B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 703.34 million and capital expenditures -143.05 million, giving a free cash flow of 560.29 million.

Operating Cash Flow	703.34M
Capital Expenditures	-143.05M
Free Cash Flow	560.29M
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 56.57%, with operating and profit margins of 21.62% and 11.14%.

Gross Margin	56.57%
Operating Margin	21.62%
Pretax Margin	10.60%
Profit Margin	11.14%
EBITDA Margin	26.70%
EBIT Margin	21.62%
FCF Margin	10.48%

Dividends & Yields

This stock pays an annual dividend of 0.56, which amounts to a dividend yield of 6.87%.

Dividend Per Share	0.56
Dividend Yield	6.87%
Dividend Growth (YoY)	-45.57%
Years of Dividend Growth	n/a
Payout Ratio	32.71%
Buyback Yield	-1.06%
Shareholder Yield	5.81%
Earnings Yield	28.44%
FCF Yield	26.73%

Dividend Details

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Organon & Co. has an Altman Z-Score of 1.27 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	1.27
Piotroski F-Score	5